Oragenics (OGEN) Accumulated Depreciation (2012 - 2023)
Oragenics' (OGEN) quarterly Accumulated Depreciation came in at $1.4 million in Q2 2023, up 0.82% on a QoQ basis from $1.4 million in Q1 2023.
Oragenics (OGEN) Accumulated Depreciation (2012 - 2023) Analysis & Trends
Oragenics (OGEN) has 12 years of Accumulated Depreciation data on file, last reported at $1.4 million in Q2 2023.
- Quarterly Accumulated Depreciation changed N/A year-over-year to $1.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.4 million (changed N/A YoY) and the FY2022 annual result came in at $1.4 million, down 16.2% from the prior year.
- Accumulated Depreciation climbed to $1.4 million in Q2 2023, from $1.4 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $1.7 million in Q4 2020 to a low of $1.4 million in Q4 2022.
- A 5-year average of $1.5 million and a median of $1.5 million in 2021 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2019 — Accumulated Depreciation increased 3.07% — and 2022, when it retreated 16.2%.
- Tracing OGEN's Accumulated Depreciation over 5 years: stood at $1.7 million in 2019, then grew by 2.96% to $1.7 million in 2020, then dropped by 5.05% to $1.6 million in 2021, then dropped by 16.2% to $1.4 million in 2022, then grew by 1.66% to $1.4 million in 2023.
- The last three Accumulated Depreciation figures came in at $1.4 million (Q2 2023), $1.4 million (Q1 2023), and $1.4 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.63 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Dec 31, 2019 | 1.66 Mn |
| Dec 31, 2018 | 1.61 Mn |
| Dec 31, 2017 | 1.58 Mn |
| Dec 31, 2016 | 1.52 Mn |
| Dec 31, 2015 | 1.45 Mn |
| Dec 31, 2014 | 1.56 Mn |
| Dec 31, 2013 | 1.53 Mn |
| Dec 31, 2012 | 1.45 Mn |